Clinical Trial Update: Safety and Efficacy of Insulin Aspart in Type 2 Diabetes [Phase 4]

View source ↗

Summary

An update on a Phase 4 trial assessing the safety and efficacy of insulin aspart in adults with Type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Insulin aspart (NovoLog) (insulin aspart)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED